ROTHBLATT MARTINE A (Chairperson & CEO) sold 19.0% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.37M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$146.03
Trade value
$1.39M
% of position
Common Stock
Shares
−295.00
Price / share
$561.53
Trade value
$165.65K
% of position
Common Stock
Shares
−1.52K
Price / share
$562.59
Trade value
$855.13K
% of position
Common Stock
Shares
−1.64K
Price / share
$563.68
Trade value
$923.31K
% of position
Common Stock
Shares
−1.37K
Price / share
$564.59
Trade value
$772.92K
% of position
Common Stock
Shares
−563.00
Price / share
$565.69
Trade value
$318.49K
% of position
Common Stock
Shares
−1.26K
Price / share
$566.72
Trade value
$714.63K
% of position
Common Stock
Shares
−1.34K
Price / share
$567.76
Trade value
$760.23K
% of position
Common Stock
Shares
−728.00
Price / share
$568.78
Trade value
$414.07K
% of position
Common Stock
Shares
−227.00
Price / share
$569.57
Trade value
$129.29K
% of position
Common Stock
Shares
−260.00
Price / share
$570.76
Trade value
$148.40K
% of position
Common Stock
Shares
−300.00
Price / share
$571.55
Trade value
$171.46K
% of position
Net shares
+0.00
Net value
-$3.99M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/28/2026 | M · Option Exercise | +9.50K | $146.03 | $1.39M | 23.4% | 40.51K | 50.01K |
| Common Stock Direct | 5/28/2026 | S · Sale | −295.00 | $561.53 | $165.65K | 0.6% | 50.01K | 49.72K |
| Common Stock Direct | 5/28/2026 | S · Sale | −1.52K | $562.59 | $855.13K | 3.1% | 49.72K | 48.20K |
| Common Stock Direct | 5/28/2026 | S · Sale | −1.64K | $563.68 | $923.31K | 3.4% | 48.20K | 46.56K |
| Common Stock Direct | 5/28/2026 | S · Sale | −1.37K | $564.59 | $772.92K | 2.9% | 46.56K | 45.19K |
| Common Stock Direct | 5/28/2026 | S · Sale | −563.00 | $565.69 | $318.49K | 1.2% | 45.19K | 44.63K |
| Common Stock Direct | 5/28/2026 | S · Sale | −1.26K | $566.72 | $714.63K | 2.8% | 44.63K | 43.37K |
| Common Stock Direct | 5/28/2026 | S · Sale | −1.34K | $567.76 | $760.23K | 3.1% | 43.37K | 42.03K |
| Common Stock Direct | 5/28/2026 | S · Sale | −728.00 | $568.78 | $414.07K | 1.7% | 42.03K | 41.30K |
| Common Stock Direct | 5/28/2026 | S · Sale | −227.00 | $569.57 | $129.29K | 0.5% | 41.30K | 41.07K |
| Common Stock Direct | 5/28/2026 | S · Sale | −260.00 | $570.76 | $148.40K | 0.6% | 41.07K | 40.81K |
| Common Stock Direct | 5/28/2026 | S · Sale | −300.00 | $571.55 | $171.46K | 0.7% | 40.81K | 40.51K |
| Total | +0.00 | -$3.99M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
146.03
Held after
145.41K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock9.50K shares | 5/28/2026 | M · Option Exercise | −9.50K | 146.03 | — | 145.41K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8.90K | Indirect |
| Common Stock | 324.44K | Indirect |
| Common Stock | 45.60K | Indirect |
| Common Stock | 166.00 | Indirect |
| Common Stock | 249.11K | Indirect |
| Total | 628.22K | 628.22K indirect |